Mr Nikolaos Chatzizacharias, Consultant Hepato-Pancreato-Biliary and Liver Transplant Surgeon in Birmingham
Mr Nikolaos Chatzizacharias
Consultant Hepato-Pancreato-Biliary and Liver Transplant Surgeon in Birmingham
Mr Nikolaos Chatzizacharias MD PhD FRCS FACS
Consultant Hepato-Pancreato-Biliary and Liver Transplant Surgeon in Birmingham
Mr Nikolaos Chatzizacharias
Consultant Hepato-Pancreato-Biliary and Liver Transplant Surgeon in Birmingham MD PhD FRCS FACS
Areas of expertise
- Abdominal pain
- Gallbladder surgery
- Liver cancer
- Liver disease
- Pancreatic cancer
Make an appointment
Address
-
The Harborne Hospital, part of HCA Healthcare UK
Mindelsohn Way, Birmingham, B15 2FQ
About Mr Nikolaos Chatzizacharias
GMC number: 6165632
Year qualified: 2004
Place of primary qualification: National Capodistrian University of Athens
Mr Nikolaos Chatzizacharias is a highly skilled consultant specialising in general surgery and hepatopancreatobiliary (HPB) surgery. Based at the Queen Elizabeth Hospital Birmingham, he has been delivering exceptional patient care since his appointment as a consultant in 2017. Mr Chatzizacharias is recognised for his expertise in managing complex conditions related to the liver, pancreas, and biliary systems.
He is adept in performing a wide range of surgical procedures, including liver resections, pancreatic surgery, and minimally invasive techniques. His areas of focus include treating conditions such as liver tumours, pancreatic cancer, bile duct disorders, and gallstone disease. With a patient-centred approach, he is dedicated to achieving the best outcomes through tailored treatment plans and advanced surgical methods.
Beyond his clinical practice, Mr Chatzizacharias holds an active role in mentoring junior doctors and contributes to research in hepatopancreatobiliary surgery. His work in this field has been widely acknowledged, reflecting his commitment to advancing surgical techniques and improving patient care.
Mr Chatzizacharias has a keen interest in integrating new technologies into surgical practice, such as robotic-assisted surgery, which enhances precision and reduces recovery times for patients. His dedication to innovation ensures that his patients benefit from cutting-edge treatments and compassionate care.
A firm advocate for medical education and research, Mr Chatzizacharias frequently participates in conferences and workshops, sharing his knowledge with peers and staying updated on the latest advancements in his field. His expertise and passion for surgery make him a trusted specialist for patients seeking effective treatment for complex HPB conditions.
Teaching posts
• Honorary Associate Clinical Professor, College of Medical and Dental Sciences, University of Birmingham (present)
• Educational Supervisor in the MSci intercalated programme, University of Birmingham Medical School (present)
• Clinical Instructor in Surgical Oncology, Medical College of Wisconsin (2016 - 2017)
Areas of expertise
- Abdominal pain
- Appendicitis
- Cancer
- Cholangiocarcinoma (bile duct cancer)
- Cholecystectomy
- Cholelithiasis (gallstones)
- Cirrhosis
- Epigastric hernia
- Eventration
- Gallbladder surgery
- Gallstones
- Hernia
- Incisional hernia
- Inguinal hernia
- Jaundice
- Liver
- Liver cancer
- Liver cyst
- Liver disease
- Liver function tests
- Liver surgery
- Liver transplant
- Lymph nodes
- Lymphadenectomy
- Metastasis
- Minimal access surgery (keyhole surgery)
- Neuroendocrine tumours
- Pancreas surgery
- Pancreatic cancer
- Pancreatic cyst
- Pancreatitis
- Radiofrequency ablation (RFA)
- Radiofrequency treatment (RFA)
- Robotic surgery
- Spleen removal
- Umbilical hernia
Professional memberships
Articles by Mr Nikolaos Chatzizacharias
Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma
Vein wall invasion is a more reliable predictor of oncological outcomes than vein-related margins after pancreaticoduodenectomy for early stages of pancreatic ductal adenocarcinoma
Arterial resection during operative management of pancreatic head and uncinate process adenocarcinoma
Staging computed tomography parameters predict the need for vein resection during pancreaticoduodenectomy in resectable pancreatic ductal adenocarcinoma
Can preoperative carbohydrate antigen 19-9 predict metastatic pancreatic cancer? Results of a systematic review and meta-analysis
Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey
Management of distal cholangiocarcinoma with arterial involvement: Systematic review and case series on the role of neoadjuvant therapy
Potential clinical utility of intraoperative fluid amylase measurement during pancreaticoduodenectomy
HPB P49 Vein wall invasion is a more reliable predictor of oncological outcomes than vein related surgical margins after pancreaticoduodenectomy for early stages of pancreatic ductal adenocarcinoma
HPB P14 Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
HPB P03 Oncological outcomes are comparable between octogenarians and younger patients after pancreatoduodenectomy for pancreatic ductal adenocarcinoma
HPB P04 The DISSECT trial, ‘The effect of periaDventitIal SMA diSsECTion on margin status during pancreaticoduodenectomy for resectable pancreatic cancer’ results of safety and feasibility pilot study
Early postoperative risk stratification in patients with pancreatic fistula after pancreaticoduodenectomy
Meta-analysis of interrupted versus continuous suturing for Roux-en-Y hepaticojejunostomy and duct-to-duct choledochocholedochostomy